For the purposes of this Regulation, the following definitions apply:
‘monitoring’ means monitoring as defined in Article 3, point (6), of Regulation (EU) 2022/2371 ;
‘public health emergency’ means a public health emergency at Union level recognised by the Commission in accordance with Article 23 of Regulation (EU) 2022/2371;
‘medical countermeasures’ means medical countermeasures within the meaning of Article 3, point (10), of Regulation (EU) 2022/2371, including personal protective equipment and substances of human origin;
‘raw materials’ means the materials required in order to produce the required quantities of crisis-relevant medical countermeasures;
‘real-world data’ means data relating to patient health status or the delivery of healthcare from sources other than clinical trials.